PDCD1 and hepatocellular carcinoma: PEGylated IFN-α can also upregulate the chemokine CCL4 secreted by tumor cells and consequently recruit cytotoxic CD8+ T cells to infiltrate the HCC microenvironment, facilitating an improvement in the antitumor effect induced by anti-PD1 treatment [59].